Eci Pharms Llc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ECI PHARMS LLC, and what generic and branded alternatives to ECI PHARMS LLC drugs are available?
ECI PHARMS LLC has two approved drugs.
Summary for Eci Pharms Llc
| US Patents: | 0 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
Drugs and US Patents for Eci Pharms Llc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eci Pharms Llc | TRIENTINE HYDROCHLORIDE | trientine hydrochloride | CAPSULE;ORAL | 209945-001 | Aug 13, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Eci Pharms Llc | XTRELUS | guaifenesin; hydrocodone bitartrate | TABLET;ORAL | 208085-001 | Apr 25, 2018 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
